Buy & Sell Novavax Inc (NVAX) – Novavax Inc Price Today
Aura AI Summary
Key Stats
- $1.70BMarket Cap
- HealthSector
- -28.7%3M Drawdown
- $1.20BEnterprise Value
- -Dividend Yield
- 68% Buy | 32% SellTrading Activity
- 57 daysTypical Hold Time
Novavax Inc (NVAX) is currently valued at a market capitalization of $1.70B, with an enterprise value of $1.20B. Over the past 52 weeks, Novavax Inc has traded between a low of $6.22 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -28.7%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 57 days, indicating typical investor behavior on the platform.
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Most Recent News
Universal Music Group rejects Pershing Square's undervalued buyout proposal, confident in growth strategy.
Universal Music Group's Board of Directors unanimously rejected an unsolicited buyout proposal from Pershing Square Capital Management, stating it undervalues the company and won't create superior value. The Board, supported by shareholders, highligh...

Broadcom gains billionaire investor as AI chip demand boosts stock and revenue forecasts.
Hedge fund billionaire Daniel Loeb increased his stake in Broadcom by buying 50,000 shares while reducing holdings in NVIDIA and Taiwan Semiconductor. Broadcom reported strong Q1 revenue of $19.31 billion, beating estimates, and expects Q2 revenue ar...

Royal Road Minerals advances drilling and permits in Colombia, eyeing world-class gold discoveries.
Royal Road Minerals is progressing its exploration in Colombia with active drilling at the GAM porphyry cluster and plans to expand across three systems this year. The company highlights strong discovery potential at El Molino and La Llanada, with si...
